Adaptive Biotechnologies Announces Private Payor Coverage of clonoSEQ for Detecting and Monitoring MRD in Patients with Lymphoid Blood Cancers, Expanding Access...
SEATTLE--(BUSINESS WIRE)--Jun 20, 2019--
SEATTLE--(BUSINESS WIRE)--Jun 20, 2019--